Back to Blog

Klotho: The Anti-Aging Protein Peptide

February 26, 2026·4 min read

Named after the Greek Fate who spins the thread of life, klotho is a protein discovered in 1997 when its absence in mice caused a syndrome of premature aging — osteoporosis, arteriosclerosis, skin atrophy, and early death. Conversely, overexpression extended mouse lifespan by 20-30%. Since then, klotho has become one of the most intensively studied longevity factors in biomedicine. Though technically a protein rather than a small peptide, its biology, research status, and therapeutic potential align it closely with the peptide medicine field.

Types of Klotho

There are three forms of klotho. Alpha-klotho is the best characterized and exists in two forms: a transmembrane form expressed primarily in kidney and brain, and a soluble form (sKlotho) cleaved from the membrane that circulates systemically and mediates most of the beneficial anti-aging effects. Beta-klotho and gamma-klotho have distinct roles in FGF signaling and uv protection.

Soluble alpha-klotho is the form targeted for therapeutic applications. It acts as a systemic hormone, circulating to organs including the brain, heart, kidney, and muscle.

Klotho and Phosphate Regulation

One of klotho's primary functions is co-receptor activity for FGF23, a hormone that regulates phosphate excretion by the kidneys. In klotho-deficient states, FGF23 cannot signal properly, causing phosphate to accumulate — driving vascular calcification, tissue aging, and organ dysfunction.

This phosphate toxicity mechanism explains many of the premature aging features seen in klotho-deficient mice and is increasingly recognized as a driver of accelerated aging in humans with kidney disease, where klotho levels plummet early in the disease course.

Cognitive and Brain Effects

Klotho has emerged as a critical factor in brain aging and cognitive resilience. Humans with a common klotho variant (KL-VS heterozygotes) have significantly higher circulating klotho levels and demonstrate better cognitive performance and reduced Alzheimer's risk — even in the presence of ApoE4, the strongest genetic Alzheimer's risk factor.

In aged mice, a single injection of soluble klotho protein at doses that raise blood levels modestly produces rapid and sustained improvements in synaptic plasticity and cognitive performance. This finding, published in Cell Reports, suggests klotho may enhance brain function acutely rather than requiring chronic administration.

Kidney and Cardiovascular Protection

Klotho is produced primarily in the kidney, and its levels fall early in chronic kidney disease (CKD). This decline accelerates disease progression through phosphate retention, FGF23 resistance, and inflammation. Supplementing klotho in CKD animal models slows disease progression, reduces fibrosis, and improves kidney function.

In the cardiovascular system, klotho suppresses vascular inflammation, inhibits endothelial cell senescence, and prevents vascular smooth muscle calcification. Low klotho is an independent predictor of cardiovascular mortality in both CKD patients and the general population.

How to Raise Klotho Levels

Given the challenges of delivering recombinant klotho protein (large molecule, poor bioavailability), several approaches to raise endogenous klotho are studied: exercise consistently increases klotho, particularly aerobic training. Vitamin D supplementation modestly raises klotho. Caloric restriction in animals boosts klotho expression. Some research suggests sirtuin activation (resveratrol, NAD+ precursors) may upregulate klotho, though human data are sparse.

Recombinant klotho protein is in early clinical trials for CKD and may eventually be available for age-related indications.

FAQ

Does klotho supplementation exist yet? Recombinant klotho is in Phase I/II trials for kidney disease. It is not commercially available. Raising endogenous klotho through exercise and vitamin D optimization is the current practical strategy.

What is a healthy klotho level? Reference ranges vary by assay. Typically, circulating sKlotho above 500-700 pg/mL is considered healthy in middle-aged adults. Levels decline approximately 10% per decade after age 40.

Can klotho reverse aging? In mice, klotho overexpression extends lifespan and reverses several aging hallmarks. Human evidence is observational. Therapeutic klotho is a genuine longevity candidate but remains experimental.

Related Articles

Track your supplements in Optimize.

Want to optimize your health?

Create your free account and start tracking what matters.

Sign Up Free